Δεκ272013Βιβλιογραφικά δεδομέναOff-Therapy Durability of Response to Entecavir Therapy in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Κατηγορία Βιβλιογραφικά δεδομένα27 Δεκεμβρίου 2013 Μοιραστείτε το! Share on FacebookShare on Facebook Share on XShare on X Share on LinkedInShare on LinkedIn Share on WhatsAppShare on WhatsApp Post navigationΠροηγούμενοPrevious post:Incidence of Colorectal Cancer After Liver Transplantation for Primary Sclerosing Cholangitis: A Systematic Review and Meta-AnalysisΕπόμενοNext post:Conversions from Prograf to Advagraf in Adolescents with stable liver transplantsΣχετικά ΆρθραPrognostic significance of mild ascites in patients with cirrhosis14 Απριλίου 2026The Rise of Transplant Oncology in Primary Liver Cancer and Metastatic Disease10 Μαρτίου 2026Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program3 Μαρτίου 2026Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis27 Φεβρουαρίου 2026Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation18 Φεβρουαρίου 2026Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis2 Φεβρουαρίου 2026
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program3 Μαρτίου 2026
Early Prognostic Factors for Reduced Survival in Autoimmune Hepatitis: A Systematic Review With Meta-Analysis27 Φεβρουαρίου 2026
Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation18 Φεβρουαρίου 2026
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis2 Φεβρουαρίου 2026
